Neijman, Marise https://orcid.org/0009-0006-1780-3055
van Alphen, Maarten J. A.
van Son, Rob J.J.H.
Stuiver, Martijn M.
Hilgers, Frans J.M.
van den Brekel, Michiel W.M.
van der Molen, Lisette
Article History
Received: 10 March 2025
Accepted: 4 August 2025
First Online: 3 October 2025
Declarations
:
: The current study was part of the approved Clinical Phase II trial (METC21.0904/N21STL). The guidelines of the Helsinki Declarations were followed.
: Written informed consent was obtained from each participant before participation.
: The authors declare that they have no conflicts of interest to disclose.